Completed NA INTERVENTIONAL 1-arm NCT02016222

Tear Analysis in the Diagnosis of Multiple Sclerosis (LARMES)

Tear Analysis in the Diagnosis of Primary Progressive Forms of Multiple Sclerosis

Sponsor: Bayer

Conditions Primary Progressive Multiple Sclerosis

Updated 6 times since 2017 Last updated: Sep 19, 2016 Started: Apr 30, 2011 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Primary Progressive Multiple Sclerosis and is currently completed. Bayer leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
Lille Catholic University

Data source: Lille Catholic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bordeaux, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Lille, France , Lyon, France , Marseille, France , Nancy, France , Nice, France , Nîmes, France and 2 more locations